Your browser doesn't support javascript.
loading
Inherited human ezrin deficiency impairs adaptive immunity.
García-Solís, Blanca; Van Den Rym, Ana; Martinez-Martínez, Laura; Franco, Teresa; Pérez-Caraballo, Jareb J; Markle, Janet; Cubillos-Zapata, Carolina; Marín, Ana V; Recio, María J; Regueiro, José R; Navarro-Zapata, Alfonso; Mestre-Durán, Carmen; Ferreras, Cristina; Martín Cotázar, Carla; Mena, Roció; de la Calle-Fabregat, Carlos; López-Lera, Alberto; Fernández Arquero, Miguel; Pérez-Martínez, Antonio; López-Collazo, Eduardo; Sánchez-Ramón, Silvia; Casanova, Jean-Laurent; Martínez-Barricarte, Rubén; de la Calle-Martín, Oscar; Pérez de Diego, Rebeca.
Affiliation
  • García-Solís B; Laboratory of Immunogenetics of Human Diseases, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain; Innate Immunity Group, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain; Interdepartmental Group of Immunodeficiencies, Madrid, Spain.
  • Van Den Rym A; Laboratory of Immunogenetics of Human Diseases, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain; Innate Immunity Group, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain; Interdepartmental Group of Immunodeficiencies, Madrid, Spain.
  • Martinez-Martínez L; Immunology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Franco T; Immunology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Pérez-Caraballo JJ; Division of Genetic Medicine, Department of Medicine, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, Tenn; Division of Molecular Pathogenesis, Department of Pathology, Microbiology, and Immunology, Vanderbilt Center for Immunobiology, Vanderbilt Institute for Infecti
  • Markle J; Division of Genetic Medicine, Department of Medicine, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, Tenn; Division of Molecular Pathogenesis, Department of Pathology, Microbiology, and Immunology, Vanderbilt Center for Immunobiology, Vanderbilt Institute for Infecti
  • Cubillos-Zapata C; Innate Immunity Group, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain; Centre for Biomedical Research Network, CIBEres, Madrid, Spain.
  • Marín AV; Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, and 12 de Octubre Health Research Institute (imas12), Madrid, Spain.
  • Recio MJ; Interdepartmental Group of Immunodeficiencies, Madrid, Spain; Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, and 12 de Octubre Health Research Institute (imas12), Madrid, Spain.
  • Regueiro JR; Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, and 12 de Octubre Health Research Institute (imas12), Madrid, Spain.
  • Navarro-Zapata A; Translational Research in Paediatric Oncology, Haematopoietic Transplantation and Cell Therapy, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Mestre-Durán C; Translational Research in Paediatric Oncology, Haematopoietic Transplantation and Cell Therapy, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Ferreras C; Translational Research in Paediatric Oncology, Haematopoietic Transplantation and Cell Therapy, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Martín Cotázar C; Translational Research in Paediatric Oncology, Haematopoietic Transplantation and Cell Therapy, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Mena R; Institute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.
  • de la Calle-Fabregat C; Epigenetics and Immune Disease Group, Joseph Carreras Research Institute (IJC), Badalona, Barcelona, Spain.
  • López-Lera A; IdiPAZ Institute for Health Research, La Paz University Hospital, CIBERER U-754, Madrid, Spain.
  • Fernández Arquero M; Interdepartmental Group of Immunodeficiencies, Madrid, Spain; Clinical Immunology Department, San Carlos Clinical Hospital, Madrid, Spain.
  • Pérez-Martínez A; Translational Research in Paediatric Oncology, Haematopoietic Transplantation and Cell Therapy, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • López-Collazo E; Innate Immunity Group, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain.
  • Sánchez-Ramón S; Interdepartmental Group of Immunodeficiencies, Madrid, Spain; Clinical Immunology Department, San Carlos Clinical Hospital, Madrid, Spain.
  • Casanova JL; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France; St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY; Imagine Institute, Universit
  • Martínez-Barricarte R; Division of Genetic Medicine, Department of Medicine, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, Tenn; Division of Molecular Pathogenesis, Department of Pathology, Microbiology, and Immunology, Vanderbilt Center for Immunobiology, Vanderbilt Institute for Infecti
  • de la Calle-Martín O; Immunology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Pérez de Diego R; Laboratory of Immunogenetics of Human Diseases, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain; Innate Immunity Group, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain; Interdepartmental Group of Immunodeficiencies, Madrid, Spain. Elect
J Allergy Clin Immunol ; 152(4): 997-1009.e11, 2023 10.
Article in En | MEDLINE | ID: mdl-37301410
ABSTRACT

BACKGROUND:

Inborn errors of immunity (IEI) are a group of monogenic diseases that confer susceptibility to infection, autoimmunity, and cancer. Despite the life-threatening consequences of some IEI, their genetic cause remains unknown in many patients.

OBJECTIVE:

We investigated a patient with an IEI of unknown genetic etiology.

METHODS:

Whole-exome sequencing identified a homozygous missense mutation of the gene encoding ezrin (EZR), substituting a threonine for an alanine at position 129.

RESULTS:

Ezrin is one of the subunits of the ezrin, radixin, and moesin (ERM) complex. The ERM complex links the plasma membrane to the cytoskeleton and is crucial for the assembly of an efficient immune response. The A129T mutation abolishes basal phosphorylation and decreases calcium signaling, leading to complete loss of function. Consistent with the pleiotropic function of ezrin in myriad immune cells, multidimensional immunophenotyping by mass and flow cytometry revealed that in addition to hypogammaglobulinemia, the patient had low frequencies of switched memory B cells, CD4+ and CD8+ T cells, MAIT, γδ T cells, and centralnaive CD4+ cells.

CONCLUSIONS:

Autosomal-recessive human ezrin deficiency is a newly recognized genetic cause of B-cell deficiency affecting cellular and humoral immunity.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytoskeleton / CD8-Positive T-Lymphocytes Limits: Humans Language: En Journal: J Allergy Clin Immunol Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytoskeleton / CD8-Positive T-Lymphocytes Limits: Humans Language: En Journal: J Allergy Clin Immunol Year: 2023 Document type: Article Affiliation country:
...